Target intelligence / Profile preview

Immunoglobulin kappa variable 1D-42 (IGKV1D-42)

Target
IGKV1D-42
Molecular classification
Other
01

Overview

Immunoglobulin kappa variable 1D-42 (IGKV1D-42) is a predicted non-functional open reading frame (ORF) belonging to the immunoglobulin kappa variable (IGKV) gene family, encoding part of the variable domain of the immunoglobulin light chains[1][5]. Non-functional immunoglobulin variable genes such as IGKV1D-42 typically do not participate in the synthesis of productive immunoglobulin light chains, usually due to disrupted V-(D)-J or switch recombination, abnormal splicing, or critical amino acid changes at the protein level[1][5]. The IGKV genes, located at chromosome 2p11.2, comprise part of the immune system's gene repertoire and are normally involved in antigen binding through the variable domains of antibodies[3][4]. However, because IGKV1D-42 is identified as a probable non-functional or pseudogene locus, it does not encode a functional protein to participate in immune response[1][5]. This gene is not considered a direct therapeutic target, disease biomarker, or druggable receptor, as it does not produce a functioning protein and has no established role in pathology or therapeutic intervention[1][5]. In summary, IGKV1D-42 is a non-functional immunoglobulin variable gene within the human IGK locus, relevant mainly for immunogenetic annotation rather than as a molecular target for therapy or biomarker research[1][5][6].

Other names
Immunoglobulin kappa variable 1D-42IGKV1D-42Probable non-functional immunoglobulin kappa variable 1D-42IGKV1D42L22

Beyond the preview

Go deeper on Immunoglobulin kappa variable 1D-42 (IGKV1D-42).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 1D-42 (IGKV1D-42).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call